Chemical Component Summary | |
---|---|
Name | 5-BROMO-2'-DEOXY URIDINE |
Identifiers | 5-bromo-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione |
Formula | C9 H11 Br N2 O5 |
Molecular Weight | 307.098 |
Type | DNA LINKING |
Isomeric SMILES | C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)Br)CO)O |
InChI | InChI=1S/C9H11BrN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16)/t5-,6+,7+/m0/s1 |
InChIKey | WOVKYSAHUYNSMH-RRKCRQDMSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 28 |
Chiral Atom Count | 3 |
Bond Count | 29 |
Aromatic Bond Count | 0 |
Drug Info: DrugBank
DrugBank ID | DB12028 |
---|---|
Name | Broxuridine |
Groups | investigational |
Description | Broxuridine has been used in trials studying the treatment of Leukemia, Stage I Prostate Cancer, Stage IIB Prostate Cancer, and Stage IIA Prostate Cancer. |
Synonyms |
|
Categories |
|
CAS number | 59-14-3 |
Related Resource References
Resource Name | Reference |
---|---|
PubChem | 6035 |
ChEMBL | CHEMBL222280 |
ChEBI | CHEBI:472552 |
CCDC/CSD | BROXUR11 |
COD | 2215590 |